Institutional investors purchased a net $801.0 thousand shares of DEPO during the quarter ended June 2015 and now own 106.32% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD ADVISERS, INC. Bought 518.7 Thousand shares of Depomed Inc